KBR Keeps Winning Contracts the Market Isn't Crediting

KBR announced Wednesday that the UK Ministry of Justice had picked it to run the new "Workplace Services Management" role at the center of the ministry's plan to overhaul how it runs its prison, probation, and court estates. On paper it is a small fish: roughly £188 million including options — call it $245 million — spread over five years with up to two option years. That works out to about $36 million a year against a company doing $8 billion. It is not a number that moves a stock by itself.

But it is worth reading anyway, because it is the latest entry in the most interesting disconnect in this stock: KBR keeps winning contracts, and the market keeps marking it down. Shares now trade around $37.90, down roughly 27% from the 12-month high of $52.23, and the 2026 scoreboard is a wall of awards: the $8 billion National Science Foundation contract to run Antarctic research, a $2.459 billion NASA astronaut-health follow-on, $449 million of U.S. Army logistics task orders, $350 million from the U.S. Geological Survey, a $95 million Space Force digital-engineering contract, and now the Ministry of Justice.

The obvious reading is that KBR is a contractor in decline. Revenue has gone nowhere this year — down 5% in the first quarter, up 2% in the second. The company was terminated from its military-household-moves venture HomeSafe in June 2025, a genuine credibility hit. It lost a $1.8 billion NASA recompete to Ascend this March. Its biggest recent award sits under protest. The market has taken the reasonable-sounding view that this is a shrinking business and priced it at about 11x trailing earnings.

The key to the story is that the shrink is dated and named, not structural. Revenue has been flat for one reason management flags every quarter: the spike in logistics work supporting U.S. forces in Europe — the EUCOM contingency scope — is rolling off exactly as expected. Fourth-quarter revenue fell 11% on "the slower pace of awards and contingency EUCOM scope reductions," the first quarter fell 5% on the same runoff, and the second quarter turned positive at plus 2% — or about plus 5% once the runoff is stripped out.

Then look at what actually improved in that second quarter. Adjusted EBITDA rose 7% to $258 million with the margin up to 13.0%. Adjusted EPS rose 9% to $0.99, about $0.08 ahead of the Street's number. Reported operating income fell 11%, but that's a $31 million pile of one-time spin-off costs sitting in the line — reported EPS of $0.75 versus $0.99 adjusted is the price of the corporate split, not a broken business. The company reaffirmed its full-year guidance for the second straight quarter: revenue of $7.90–8.36 billion, adjusted EBITDA of $980 million–1.04 billion, and adjusted EPS of $3.87–4.22.

The orders support the same reading. Backlog plus options finished June at $23.0 billion on a 1.1x book-to-bill, and that excludes another $10.6 billion of awarded work still under protest. The process-technology side that will survive as "new KBR" posted a record $5.5 billion backlog and a 1.5x book-to-bill. Order books up, stock down.

That is where the Ministry of Justice award fits. It is too small to move the financials, but it is a retained relationship, not a one-off: KBR has been the ministry's facilities-management integrator for years, and this hands it the "workplace services management" brain of the transformed prison and probation program, with the courts estate as a possible add-on. It is recurring international-government work — the same pool KBR credited for its growth this quarter, pointing to the UK and Australia — and it lands inside the business that is about to be spun off on its own.

That split is the scheduled catalyst. KBR plans to spin its Mission Technology Solutions division into a separate public company called Trinzic on January 4, 2027, in what it intends to be a tax-free transaction, with investor days for both companies scheduled for November. The move forces the market to stop valuing a blended conglomerate, and the building blocks are already public: in fiscal 2025 the government arm did $5.58 billion of revenue with about $579 million of segment adjusted EBITDA, while the surviving process-technology and engineering business did $2.2 billion and $497 million at adjusted margins near 20%. Those are two different investment cases wearing one stock.

Put the price to work. At $37.90, the market is paying about 9.4x the midpoint of the company's own reaffirmed adjusted-EPS guidance — cheaper than the low-teens multiples its larger government-services peers carry even on trailing earnings. Enterprise value of roughly $7 billion against about a billion of guided adjusted EBITDA gets to near 7x. Toss in a roughly 1.8% dividend from a company that has paid one for 17 straight years, and the stock is not merely value-priced; it is priced as if the decline continues forever.

The discount is only worth taking with the break conditions named. The Antarctic award, worth $8 billion as a ceiling over 20 years, is being challenged by Battelle in a formal protest that argues the NSF failed to account for KBR's spin-off; lose it and the un-booked $10.6 billion gets smaller and the "international engine" story thins. NASA, a major federal-civilian customer already shifting work toward civil servants, just handed a $1.8 billion recompete to a competitor. And the process-technology margin dipped to 18.2% last quarter from 21.9% on project mix — management says it recovers, and a skeptic will want to see that. Any one of those can keep the discount in place.

Here is the honest way to frame it. The MoJ award is small and strategic at once: proof that a durable international-government franchise keeps recompeting and winning while the market prices in its death. The math behind the flat revenue is a dated runoff plus corporate split noise, and the stock at about 9.4x the adjusted earnings the company says it will deliver this year already pays you to find out whether the January split proves the market's decline forecast or the company's guidance was right. That is the whole trade in one multiple: at roughly 9x forward adjusted earnings with the backlog to back it, the stock does not price in the business that is already visible — and if the protest or the budget knife lands first, it still doesn't cost you much, because the bad news is already in the price.